Financial reports and presentations

VACCIBODY WILL PRESENT PRELIMINARY SAFETY, EFFICACY AND IMMUNOGENICITY RESULTS FROM ITS PHASE 1/2A (DIRECT-01) STUDY OF CANCER NEOANTIGEN VACCINE VB10.NEO IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS

Download
Warning: Undefined array key "HTTP_REFERER" in /var/www/0/351003/www/wp-content/themes/nykode-understrap-child/loop-templates/content-single-financial.php on line 67

Go back